Ignelzi Troy A. 4
4 · Karuna Therapeutics, Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-05-23$222.24/sh−2,093$465,148→ 36,670 total - Sale
Common Stock
2023-05-23$225.19/sh−1,022$230,144→ 31,269 total - Sale
Common Stock
2023-05-23$225.93/sh−782$176,677→ 30,487 total - Sale
Common Stock
2023-05-23$224.19/sh−1,070$239,883→ 32,291 total - Exercise/Conversion
Option (right to buy)
2023-05-23−9,000→ 94,726 totalExercise: $9.20Exp: 2029-03-21→ Common Stock (9,000 underlying) - Exercise/Conversion
Common Stock
2023-05-23$9.20/sh+9,000$82,800→ 39,487 total - Sale
Common Stock
2023-05-23$221.28/sh−724$160,207→ 38,763 total - Sale
Common Stock
2023-05-23$223.21/sh−3,309$738,602→ 33,361 total
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.72 to $221.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (7) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.72 to $222.71, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.72 to $223.69, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.72 to $224.71, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.73 to $225.66, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.73 to $226.26, inclusive.
- [F8]This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.